Rating
Buy
Price target
$100
Previous
$105
Implied upside
+28%

Mizuho analyst Vijay Rakesh lowered the price target on General Motors (NYSE: GM) to $100.00 (from $105.00) while maintaining a Outperform rating.

“GM reported good MarQ with Rev/EPS of $43.6B/$3.70 (cons. $43.4B/$2.60), wholesale Auto units ~899K, (down ~1% y/y better vs. LVP down 3%) and ATP up 3% y/y.

Key Highlights: 1) raised 2026E EBIT/EPS guide to $14.5B/$12.50, above consensus $12.3B/$11.79 (prior $14.0B/$12.00) with lower $3B tariffs (prior: $3.5B) from a ~$0.5B IEEPA tariff refund, 2) Inventory at ~47 days a tailwind into Q2/2H26 with 50-60 day targets, 3) EV restructuring completing by 2026E-end while 2026E NA ASP reiterated at flat-to-up y/y, 4) raised 2026E cost headwinds to $1.75B (prior $1.25B) with steel px potentially up >50% y/y, higher freight and memory cost, and 5) Reiterating NA EBIT 8-10% target as we see better warranty expense, stronger volumes with inventory replenishment.

Maintain Outperform, Adjust Est/PT to $100 (prior $105).

We remain positive on GM L-T with lower tariff costs and leadership in ICE SUV/pickups, despite N-T cost headwinds.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.